The chief executive of health watchdog Nice told ITV News he is "disappointed" that drug manufacturer Roche has not offered the NHS a discount on a breast cancer drug that costs around £90,000 per patient.
Kadcyla, which extends women's lives by almost six months, could be blocked from routine NHS access because it is too expensive.
"Companies can discount their prices and they frequently do. Given the list price. I would have expected the company to have at least considered (a discount)," Andrew Dillon said.
More top news
An intrepid group of activists is taking its message of independence to new heights by leaving giant 'Yeses' on hillsides across Scotland.
Newly-released documents reveal how British spymasters used an enticing female agent to test the mettle of rookie spies.
Researchers studying the King's remains believe he died after sustaining numerous blows to the head.